Dow Up 1.52% Nasdaq Up 1.68%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
183.94 Up 10.67(6.16%) 11:37AM EDT - Nasdaq Real Time Price
Prev Close:173.27
Open:179.74
Bid:183.65 x 100
Ask:183.88 x 200
1y Target Est:198.57
Beta:1.07
Next Earnings Date:23-Oct-14ALXN Earnings announcement
Day's Range:177.72 - 184.88
52wk Range:110.67 - 185.43
Volume:990,378
Avg Vol (3m):1,179,410
Market Cap:36.39B
P/E (ttm):92.20
EPS (ttm):2.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALXNUp 6.16%36.39B
AMGNUp 2.76%112.12B
BAXUp 1.27%37.51B

Key Statistics

Forward P/E (1 yr):32.05
P/S (ttm):17.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback